Owens & Minor Reports Q2 2025 Earnings and Strategic Shift

Owens & Minor ( (OMI) ) has released its Q2 earnings. Here is a breakdown of the information Owens & Minor presented to its investors.

Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company that provides essential products and services supporting care from hospitals to homes, with a focus on delivering comfort and confidence in healthcare environments.

In its latest earnings report for the second quarter of 2025, Owens & Minor announced the classification of its Products & Healthcare Services segment as discontinued operations, reflecting its strategic shift towards becoming a pure-play Patient Direct business. The company reported solid performance and growth in its continuing operations, primarily represented by the Patient Direct segment.

Key financial highlights include a revenue increase to $681.9 million from $660.4 million in the same quarter last year. Despite a GAAP net loss from continuing operations of $83.8 million, the company reported an adjusted net income of $20.5 million, up from $19.3 million in the previous year. Adjusted EBITDA also showed growth, reaching $96.6 million compared to $91.1 million in the prior year. These results underscore the company’s focus on strategic realignment and operational efficiency.

The company is in the final stages of selling its Products & Healthcare Services segment, which is expected to enhance its focus on the Patient Direct business. This move is anticipated to better support long-term growth and customer needs, leveraging favorable demographic trends and the company’s meaningful scale in the market.

Looking ahead, Owens & Minor’s management remains optimistic about the opportunities in the Patient Direct space, confident in their ability to lead and adapt as the market evolves. The company’s strategic focus and operational momentum are expected to drive future growth and performance.